Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating DWJ1464 in patients with chronic liver disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• DWJ1464

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Chronic Liver Disease | Phase 4 | Status: COMPLETED